Aminosalicylates for induction of remission or response in Crohn's disease-Reference-Cited by-同舟云学术

Aminosalicylates for induction of remission or response in Crohn's disease

Published:2016-07-03 Issue:7 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Lim Wee-Chian¹,Wang Yongjun²,MacDonald John K³⁴,Hanauer Stephen⁵

Affiliation:

1. Tan Tock Seng Hospital; Department of Gastroenterology and Hepatology; 11 Jalan Tan Tock Seng Singapore Singapore S 308433

2. University of Western Ontario; Schulich School of Medicine & Dentistry; London ON Canada

3. Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6

4. University of Western Ontario; Department of Medicine; London ON Canada

5. Northwestern University Feinberg School of Medicine; 676 N St Clair Suite 1400 Chicago IL USA 60611

Publisher

Wiley

Subject

Pharmacology (medical)

Reference135 articles.

1. Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials;Hanauer;Clinical Gastroenterology and Hepatology,2004

2. Hoechst Marion Roussel Inc Clinical study report: efficacy and safety of oral Pentasa in the treatment of active Crohn's disease (Crohn's III)

3. Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group;Gross;Zeitschrift fur Gastroenterologie,1995

4. Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease;Mahida;Digestion,1990

5. Successful acute treatment of chronic inflammatory intestinal diseases with oral 5-aminosalicylic acid;Maier;Deutsche Medizinische Wochenschrift,1985

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA methylation in inflammatory bowel disease;Cancer Science;2024-01-23

2. Discovering the Nutrition-Microbiota Interplay in Inflammatory Bowel Disease: Are We There Yet?;Endocrinology;2024

3. Biofilm's Impact on Inflammatory Bowel Diseases;Cureus;2023-09-18

4. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease;Drugs;2023-07-28

5. Analysis of Crohn´s disease pharmacotherapy in the child and adult population;Klinická farmakologie a farmacie;2023-07-10